I agree that this site is using cookies. You can find further informations here.
X
Bouabdallah, K.
211  results:
Search for persons X
?
1

REALMA: Subset of patients with Marginal Zone Lymphomas fro..:

Bommier, C. ; Donzel, M. ; Rossi, C....
Hematological Oncology.  41 (2023)  S2 - p. 387-388 , 2023
Link: https://doi.org/10.1002/..
 
?
2

VERY LONG‐TERM FOLLOW‐UP OF RITUXIMAB MAINTENANCE IN YOUNG ..:

Sarkozy, C. ; Thieblemont, C. ; Oberic, L....
Hematological Oncology.  41 (2023)  S2 - p. 151-152 , 2023
Link: https://doi.org/10.1002/..
 
?
3

Final safety and efficacy results of copanlisib monotherapy..:

Dreyling, M. ; Santoro, A. ; Mollica, L....
Hematological Oncology.  41 (2023)  S2 - p. 560-562 , 2023
Link: https://doi.org/10.1002/..
 
?
4

Allogeneic transplantation in T‐cell lymphoma: Lessons from..:

Tournilhac, O. ; Altmann, B. ; Friedrichs, B....
Hematological Oncology.  41 (2023)  S2 - p. 512-513 , 2023
Link: https://doi.org/10.1002/..
 
?
5

CLONAL ARCHITECTURE OF RELAPSED OR REFRACTORY FOLLICULAR HE..:

Loyaux, R. ; Sako, N. ; Quang, V. Tran...
Hematological Oncology.  41 (2023)  S2 - p. 108-110 , 2023
Link: https://doi.org/10.1002/..
 
?
6

Combination of pixantrone with rituximab, ifosfamide and et..:

Fornecker, L. ; Delwail, V. ; Thieblemont, C....
Hematological Oncology.  41 (2023)  S2 - p. 437-437 , 2023
Link: https://doi.org/10.1002/..
 
?
7

ZANUBRUTINIB PLUS OBINUTUZUMAB VERSUS OBINUTUZUMAB IN PATIE..:

Zinzani, P. L. ; Mayer, J. ; Trotman, J....
Hematological Oncology.  41 (2023)  S2 - p. 119-121 , 2023
Link: https://doi.org/10.1002/..
 
?
8

Cell‐free DNA sequencing allows the identification of the m..:

Sako, N. ; Delfau, M. ; Bachy, E....
Hematological Oncology.  41 (2023)  S2 - p. 338-339 , 2023
Link: https://doi.org/10.1002/..
 
?
9

Long term follow‐up of untreated/relapsing MCL patients wit..:

Le Gouill, S. ; Morschhauser, F. ; Chiron, D....
Hematological Oncology.  41 (2023)  S2 - p. 478-479 , 2023
Link: https://doi.org/10.1002/..
 
?
10

Transfusion needs after CD19 CAR T‐cells for large B‐cell l..:

Vic, S. ; Thibert, J. ; Bachy, E....
Hematological Oncology.  41 (2023)  S2 - p. 534-536 , 2023
Link: https://doi.org/10.1002/..
 
?
11

P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PAT..:

Zinzani, P. L. ; Özcan, M. ; Sapunarova, K....
HemaSphere.  6 (2022)  - p. 1028-1029 , 2022
Link: https://doi.org/10.1097/..
 
?
12

P1133: SUB-CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT ..:

Cartron, G. ; Bachy, E. ; Tilly, H....
HemaSphere.  6 (2022)  - p. 1023-1024 , 2022
Link: https://doi.org/10.1097/..
 
?
13

P1186: A LARGE FRENCH REAL WORLD MULTICENTRIC PROSPECTIVE C..:

Ghesquieres, H. ; Cherblanc, F. ; Belot, A....
HemaSphere.  6 (2022)  - p. 1072-1073 , 2022
Link: https://doi.org/10.1097/..
 
?
14

S205: ZANUBRUTINIB + OBINUTUZUMAB (ZO) VS OBINUTUZUMAB (O) ..:

Zinzani, P. L. ; Mayer, J. ; Auer, R....
HemaSphere.  6 (2022)  - p. 106-107 , 2022
Link: https://doi.org/10.1097/..
 
?
15

GENDER DISPARITIES IN QUALITY OF LIFE OF FRENCH PATIENTS ON..:

Paunescu, A.‐C. ; Paget, J. ; Bergman, C. Copie...
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
1-15